Waters Corp.WAT

Health Care · Health Care Equipment & Services · NYSE · United States · waters.com

Waters Corporation is a global leader in analytical instruments, separations technologies, and software, serving the life sciences, materials, food, and environmental sciences industries since 1958. The company designs and manufactures liquid chromatography, mass spectrometry, and thermal analysis instruments along with related software and consumables used in pharmaceutical research, quality testing, and scientific analysis. Headquartered in Milford, Massachusetts, Waters operates two segments — Waters and TA Instruments — and serves customers in over 100 countries with more than 7,800 employees.

Key ratios

Operating cash flow growth

-26.3%TTM

2025 -14.4%2024 26.4%2023 -1.5%

EPS growth

-80.0%TTM

2025 0.5%2024 -1.2%2023 -7.6%

FCF / Sales

8.6%TTM

2025 17.1%2024 20.9%2023 15.0%

Net margin

3.6%TTM

2025 20.3%2024 21.6%2023 21.7%

ROA

11.5%TTM

2025 11.5%2024 11.7%2023 13.6%

ROE

1.9%TTM

2025 29.3%2024 42.8%2023 77.6%

Revenue growth

52.5%TTM

2025 7.0%2024 0.1%2023 -0.5%

Recent news

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer 2026-09-14 · CNW Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer 2026-07-27 · Cision/CNW IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine 2026-06-24 · PR Newswire Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics 2026-06-01 · PR Newswire

Track WAT in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer